Filing Flows › Medline (MDLN) › Capital expenditures
Medline (MDLN) capital expenditures by quarter
Medline's capital expenditures were $141M in Q3 2026 (third quarter 2026), +27% from Q2 2026. Over the last 3 quarters it ranged from $96.0M (Q1 2026) to $141M (Q3 2026).
| Quarter | Capital expenditures | Q/Q | Y/Y |
|---|---|---|---|
| Q3 2026 | $141M | +27% | — |
| Q2 2026 | $111M | +16% | — |
| Q1 2026 | $96.0M | — | — |
Q3 2026 at a glance
Medline, Q3 2026: revenue $7.9B (+10% year over year), operating margin 6.4%, net earnings $198M, operating cash flow $1.0B. The chart follows the revenue to costs, profit and cash.
Questions
What is Medline's capital expenditures?
Medline's capital expenditures were $141M in Q3 2026 (third quarter 2026), +27% from Q2 2026.
How has Medline's capital expenditures changed?
Over the last 3 quarters it ranged from $96.0M (Q1 2026) to $141M (Q3 2026).